Polymeric nanocapsules: a potential new therapy for corneal wound healing

Corneal injuries are one of the most frequently observed ocular diseases, leading to permanent damage and impaired vision if they are not treated properly. In this sense, adequate wound healing after injury is critical for keeping the integrity and structure of the cornea. The goal of this work was to assess the potential of polymeric nanocapsules, either unloaded or loaded with cyclosporine A or vitamin A, alone or in combination with mitomycin C, for the treatment of corneal injuries induced by photorefractive keratectomy surgery. The biopolymers selected for the formation of the nanocapsules were polyarginine and protamine, which are known for their penetration enhancement effect. The results showed that, following topical instillation to a mouse model of corneal injury, all the nanocapsule formulations, either unloaded or loaded with cyclosporine A or vitamin A, were able to stimulate corneal wound healing. In addition, the healing rate observed for the combination of unloaded protamine nanocapsules with mitomycin C was comparable to the one observed for the positive control Cacicol®, a biopolymer known as a corneal wound healing enhancer. Regarding the corneal opacity, the initial grade of corneal haze (>3) induced by the photorefractive keratectomy was more rapidly reduced in the case of the positive control, Cacicol®, than in corneas treated with the nanocapsules. In conclusion, this work shows that drug-free arginine-rich (polyarginine, protamine) nanocapsules exhibit a positive behavior with regard to their potential use for corneal wound healing.

[1]  Jian Yang,et al.  Diazeniumdiolation of protamine sulfate reverses mitogenic effects on smooth muscle cells and fibroblasts. , 2015, Free radical biology & medicine.

[2]  M. Kim,et al.  The wound healing effects of vitamin A eye drops after a corneal alkali burn in rats , 2012, Acta ophthalmologica.

[3]  M. de la Fuente,et al.  Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cells , 2008, The journal of gene medicine.

[4]  J. Merayo-Lloves,et al.  Efectos de nuevos agentes regenerativos biomiméticos sobre la cicatrización corneal en un modelo experimental de úlceras posquirúrgicas , 2015 .

[5]  J. Warnet,et al.  RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies. , 2013, Journal francais d'ophtalmologie.

[6]  R. Mohan,et al.  A novel method for generating corneal haze in anterior stroma of the mouse eye with the excimer laser. , 2006, Experimental eye research.

[7]  Q. Garrett,et al.  Corneal Injuries and Wound Healing - Review of Processes and Therapies , 2014 .

[8]  U. Kompella,et al.  Pirfenidone Nanoparticles Improve Corneal Wound Healing and Prevent Scarring Following Alkali Burn , 2013, PloS one.

[9]  J. Merayo-Lloves,et al.  Wound healing following refractive surgery in hens. , 2006, Experimental eye research.

[10]  M. Fini,et al.  How the Cornea Heals: Cornea-specific Repair Mechanisms Affecting Surgical Outcomes , 2005, Cornea.

[11]  Steven E. Wilson,et al.  Cellular and extracellular matrix modulation of corneal stromal opacity. , 2014, Experimental eye research.

[12]  Francisco Orallo,et al.  Design of New Formulations for Topical Ocular Administration: Polymeric Nanocapsules Containing Metipranolol , 2004, Pharmaceutical Research.

[13]  A. Hutcheon,et al.  Kinetics of keratocyte proliferation in response to epithelial debridement. , 2001, Experimental eye research.

[14]  Effects of new biomimetic regenerating agents on corneal wound healing in an experimental model of post-surgical corneal ulcers. , 2015 .

[15]  P. Daull,et al.  Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model , 2012, Molecular vision.

[16]  A. Delcampe,et al.  Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers. , 2012, Investigative ophthalmology & visual science.

[17]  M. Alonso,et al.  Improvement of Ocular Penetration of Amikacin Sulphate by Association to Poly(butylcyanoacrylate) Nanoparticles , 1991, The Journal of pharmacy and pharmacology.

[18]  R. Diegelmann,et al.  Protamine selectively inhibits collagen synthesis by human intestinal smooth muscle cells and other mesenchymal cells , 1989, Journal of cellular physiology.

[19]  T. Wynn,et al.  Cytokine mediated tissue fibrosis. , 2013, Biochimica et biophysica acta.

[20]  G. Schlunck,et al.  Extracellular matrix elasticity modulates TGF-β-induced p38 activation and myofibroblast transdifferentiation in human tenon fibroblasts. , 2011, Investigative ophthalmology & visual science.

[21]  S. Wilson.  Corneal myofibroblast biology and pathobiology: generation, persistence, and transparency. , 2012, Experimental eye research.

[22]  J. Zieske,et al.  Topical Mitomycin-C enhances subbasal nerve regeneration and reduces erosion frequency in the debridement wounded mouse cornea. , 2016, Experimental eye research.

[23]  R. Mohan,et al.  Stromal haze, myofibroblasts, and surface irregularity after PRK. , 2006, Experimental eye research.

[24]  Kyung-Min Lim,et al.  The effect of epidermal growth factor (EGF) conjugated with low-molecular-weight protamine (LMWP) on wound healing of the skin. , 2012, Biomaterials.

[25]  M. V. Lozano,et al.  Polyarginine nanocapsules: a new platform for intracellular drug delivery , 2013, Journal of Nanoparticle Research.

[26]  U. Bhawal,et al.  The Pro-Healing Effect of Protamine-Hydrolysate Peptides on Skin Wounds Involves TGF-β/Smad Signaling , 2015 .

[27]  G O Waring,et al.  Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. , 1990, Archives of ophthalmology.

[28]  Á. González-Fernández,et al.  Protamine-based nanoparticles as new antigen delivery systems. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[29]  G. Klintworth,et al.  A refractive and histopathologic study of excimer laser keratectomy in primates. , 1990, American journal of ophthalmology.

[30]  W. T. Chen,et al.  Radial keratotomy. II. Role of the myofibroblast in corneal wound contraction. , 1992, Investigative ophthalmology & visual science.

[31]  M. Ferrari,et al.  Polyarginine induces an antitumor immune response through binding to toll-like receptor 4. , 2014, Small.

[32]  M. Garcia‐Fuentes,et al.  A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[33]  M. Srinivasan,et al.  Corneal blindness: a global perspective. , 2001, Bulletin of the World Health Organization.

[34]  M. Alonso,et al.  A new drug nanocarrier consisting of polyarginine and hyaluronic acid. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[35]  N. Mizuki,et al.  The "Crocodile Technique": A New Ophthalmic Surgical Technique to Remove Subretinal Proliferative Tissue Associated with Retinal Detachment , 2014 .

[36]  M. Alonso,et al.  Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[37]  M. Alonso,et al.  Bioadhesive hyaluronan–chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue , 2008, Gene Therapy.

[38]  A Singh,et al.  Corneal epithelial wound healing. , 1994, The British journal of ophthalmology.

[39]  M. Alonso,et al.  Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. , 2001, International journal of pharmaceutics.

[40]  G. Orive,et al.  Plasma rich in growth factors (PRGF-Endoret) stimulates corneal wound healing and reduces haze formation after PRK surgery. , 2013, Experimental eye research.

[41]  Steven E. Wilson,et al.  Corneal myofibroblast generation from bone marrow-derived cells. , 2010, Experimental eye research.

[42]  M. L. Salvetat,et al.  Human Adipose-Derived Stem Cells for the Treatment of Chemically Burned Rat Cornea: Preliminary Results , 2013, Current eye research.

[43]  Ruxandra Gref,et al.  The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[44]  Clive G. Wilson,et al.  Nanostructures overcoming the ocular barrier : physiological considerations and mechanistic issues , 2012 .

[45]  M. de la Fuente,et al.  Nanotherapies for the treatment of ocular diseases. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[46]  Sky K Chew,et al.  Retinoic acid and the ocular surface. , 2015, Survey of ophthalmology.

[47]  J. Pastor,et al.  Polyester Nanocapsules as New Topical Ocular Delivery Systems for Cyclosporin A , 1996, Pharmaceutical Research.

[48]  Y. Yamaguchi,et al.  Effects of all-trans retinoic acid nanoparticles on corneal epithelial wound healing , 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.

[49]  S. W. Kim,et al.  Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study , 2003, The journal of gene medicine.

[50]  X. Li,et al.  Toll-like receptor 4 promotes fibrosis in bleomycin-induced lung injury in mice. , 2015, Genetics and molecular research : GMR.

[51]  Cheol Moon,et al.  Synthetic skin-permeable proteins enabling needleless immunization. , 2010, Angewandte Chemie.

[52]  V. Holan,et al.  The healing of alkali-injured cornea is stimulated by a novel matrix regenerating agent (RGTA, CACICOL20): a biopolymer mimicking heparan sulfates reducing proteolytic, oxidative and nitrosative damage. , 2014, Histology and histopathology.

[53]  Alejandro Sánchez,et al.  Chitosan Nanoparticles as New Ocular Drug Delivery Systems: In Vitro Stability, in Vivo Fate, and Cellular Toxicity , 2005, Pharmaceutical Research.

[54]  S. Benita,et al.  Evaluation of a positively charged submicron emulsion of piroxicam on the rabbit corneum healing process following alkali burn. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[55]  María J Alonso,et al.  Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). , 2007, Biomaterials.

[56]  J. Mehta,et al.  ITF2357 transactivates Id3 and regulate TGFβ/BMP7 signaling pathways to attenuate corneal fibrosis , 2016, Scientific Reports.

[57]  A. Ljubimov,et al.  Progress in corneal wound healing , 2015, Progress in Retinal and Eye Research.

[58]  S. Saika,et al.  Impairment of corneal epithelial wound healing in a TRPV1-deficient mouse. , 2014, Investigative ophthalmology & visual science.

[59]  K. Meek,et al.  Corneal structure and transparency , 2015, Progress in Retinal and Eye Research.

[60]  M. V. Lozano,et al.  Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers. , 2008, Biomacromolecules.

[61]  M. Alonso,et al.  Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers , 1997 .

[62]  I. Aslanides,et al.  A pharmacological modification of pain and epithelial healing in contemporary transepithelial all-surface laser ablation (ASLA) , 2015, Clinical ophthalmology.

[63]  J. Robinson,et al.  Study of the mechanism of interaction of poly(ϵ-caprolactone) nanocapsules with the cornea by confocal laser scanning microscopy , 1994 .

[64]  Xiangrong Zhang,et al.  Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. , 2011, International journal of pharmaceutics.

[65]  M. Alonso,et al.  Improved Ocular Bioavailability of Indomethacin by Novel Ocular Drug Carriers , 1996, The Journal of pharmacy and pharmacology.

[66]  M. Alonso,et al.  Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. , 1996, Journal of pharmaceutical sciences.

[67]  D. Barritault,et al.  Les agents de rgnration (ou RGTAs) : une nouvelle approche thrapeutique , 2006 .

[68]  W. Petroll,et al.  Corneal stromal wound healing in refractive surgery: the role of myofibroblasts , 1999, Progress in Retinal and Eye Research.